Analyze Diet

Effect of yohimbine on xylazine-induced hypoinsulinemia and hyperglycemia in mares.

Abstract: Serum insulin and plasma glucose concentrations were determined in 8 mares. Four IV treatments were studied: xylazine (1.1 mg/kg of body weight); yohimbine (0.125 mg/kg); yohimbine (0.125 mg/kg) followed 5 minutes later by xylazine (1.1 mg/kg); and 5 ml of isotonic saline solution as a control. Blood samples were collected before (time 0) and at 5, 15, 30, 60, 120, and 180 minutes after drug administration. Serum insulin concentration decreased and plasma glucose concentration increased in mares given xylazine. Plasma glucose concentration was unchanged in control mares and in mares given yohimbine or yohimbine followed by xylazine. Serum insulin concentration was unchanged in mares given saline solution, but transiently increased in mares given yohimbine alone. Treatment with yohimbine prevented xylazine-induced hypoinsulinemia and hyperglycemia.
Publication Date: 1987-04-01 PubMed ID: 3296886
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigated how yohimbine, a drug often used to reverse the effects of anesthesia in animals, can counteract the impact of the drug xylazine on insulin and glucose levels. The authors found that yohimbine successfully prevented the decrease in insulin and increase in glucose caused by xylazine in horse populations.

Experimental Design and Procedure

  • The study involved eight mares and four intravenously-administered drug treatments were tested: xylazine, yohimbine, yohimbine followed by xylazine, and isotonic saline used as a control.
  • The purpose of using different combinations of drugs was to observe and evaluate their effects on serum insulin and plasma glucose concentrations in the mares.
  • Blood samples were taken at several intervals, starting from before drug administration (time 0) and then after 5, 15, 30, 60, 120, and 180 minutes of administering the drugs.

Research Findings

  • Mares that were given xylazine experienced a decrease in serum insulin concentration and an increase in plasma glucose concentration.
  • On the other hand, this effect on plasma glucose concentration wasn’t observed in any of the other groups – the control mares given saline, mares given yohimbine alone, or those given yohimbine followed by xylazine.
  • Interestingly, there was a transient increase in serum insulin levels in the horses that received yohimbine alone. In the saline control group, the serum insulin level remained unchanged.
  • The main finding of the research is that yohimbine treatment effectively prevented the hypoinsulinemia (low insulin levels) and hyperglycemia (high blood glucose levels) that were induced by the administration of xylazine.

Implications of the Research

  • These results show that yohimbine has the potential to be used to counteract the undesirable metabolic effects of xylazine, namely decreasing insulin levels and increasing glucose levels.
  • Yohimbine could therefore be utilized in treating conditions related to insulin and glucose levels, especially in situations where xylazine has been used.
  • The results of this study can impact future research in equine medical treatments and may broaden the potential applications of yohimbine in veterinary practice.

Cite This Article

APA
Greene SA, Thurmon JC, Tranquilli WJ, Benson GJ. (1987). Effect of yohimbine on xylazine-induced hypoinsulinemia and hyperglycemia in mares. Am J Vet Res, 48(4), 676-678.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 48
Issue: 4
Pages: 676-678

Researcher Affiliations

Greene, S A
    Thurmon, J C
      Tranquilli, W J
        Benson, G J

          MeSH Terms

          • Animals
          • Blood Glucose / analysis
          • Female
          • Horse Diseases / chemically induced
          • Horse Diseases / prevention & control
          • Horses
          • Hyperglycemia / chemically induced
          • Hyperglycemia / prevention & control
          • Hyperglycemia / veterinary
          • Insulin / blood
          • Thiazines / adverse effects
          • Xylazine / adverse effects
          • Yohimbine / pharmacology

          Citations

          This article has been cited 2 times.
          1. Grimsrud KN, Ait-Oudhia S, Durbin-Johnson BP, Rocke DM, Mama KR, Rezende ML, Stanley SD, Jusko WJ. Pharmacokinetic and pharmacodynamic analysis comparing diverse effects of detomidine, medetomidine, and dexmedetomidine in the horse: a population analysis.. J Vet Pharmacol Ther 2015 Feb;38(1):24-34.
            doi: 10.1111/jvp.12139pubmed: 25073816google scholar: lookup
          2. Liu S, Zhen G, Meloni BP, Campbell K, Winn HR. RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).. J Exp Stroke Transl Med 2009 Jan 1;2(2):2-27.
            doi: 10.6030/1939-067x-2.2.2pubmed: 20369026google scholar: lookup